424B5 ·Filed Sep 8, 2026

SNN

SMITH & NEPHEW PLC
NEUTRAL
Impact 4/10
Horizonweeks Processed23d 1h ago SEC0000950103-26-013643
Notable filing: 424B5
Actionable Insight • Neutral

This is a liability management transaction, not a fundamental change. Monitor the tender offer results (expires Sept 15, 2026) for the final take-up rate on the 2030 notes. The new notes will trade based on SNN's credit quality, not equity fundamentals. No immediate read-through for SNN common stock.

DirectionNeutral
Confidencehigh
Horizonweeks
Latest settled — T+5d ⚠ clustered
SNN ▲ +0.50% at T+5d
NEUTRAL call ✓ call won +0.50% · α vs SPY +1.62% · entry $27.87 → $28.01
Next anchor: T+20d in 4d
Latest observation: T+13 -0.21% FF3 residual α
Entry anchored
Sep 8, 05:01 AM ET
via 1-min bar
T+1d
-0.25%
call -0.25% · α +0.21%
$27.80
settled 23d ago
T+5d
+0.50%
call +0.50% · α +1.62%
$28.01
settled 17d ago
T+20d
—
call — · α —
—
in 4d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

Smith & Nephew is issuing an undisclosed amount of 10-year senior unsecured notes due 2036, with proceeds intended to fund a concurrent tender offer for up to $250M of its 2.032% Senior Notes due 2030 (of which $900M is outstanding). The offering is a debt refinancing — replacing near-term maturities with longer-dated paper — and does not change the company's overall leverage profile or equity value. The filing is a routine capital markets transaction with no material impact on SNN common stock fundamentals.

Key Facts

  • Smith & Nephew is offering an undisclosed amount of % Notes due 2036 under a shelf registration.
  • Net proceeds will fund purchases of up to $250M of its 2.032% Senior Notes due 2030 via a concurrent tender offer expiring September 15, 2026.
  • The 2030 Tender Offer Notes have $900M aggregate principal outstanding; the tender is capped at $250M.
  • The new notes are unsecured, unsubordinated, and rank equally with existing unsecured debt.
  • Application will be made to list the notes on the NYSE.
  • H1 2026 revenue was $3,097M (up 4.6% YoY from $2,961M); operating profit was $448M (up 4.4% YoY from $429M).
  • Cash and cash equivalents stood at $750M as of June 27, 2026; total debt was $3,588M.
  • The offering is not conditioned on the tender offer, but the tender offer requires this offering to close.

Financial Impact

Debt refinancing — new 10-year notes replace up to $250M of 2030 notes (4-year maturity extension). No change in total debt or equity; net leverage unchanged.

debt maturity profileinterest expense

Risk Factors

  • Tender offer may not be completed as planned, leaving proceeds used for general corporate purposes instead of debt reduction.
  • Change of Control Repurchase Event clause requires 101% repurchase if both a change of control and ratings downgrade to below investment grade occur.
  • Cross-default provision triggers at $50M threshold on other indebtedness.

Market Snapshot

Exchange
OTC
Sector
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Analyst Consensus
46% bullish (24 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
424B5 Filing (Primary)0000950103-26-013643
Document: 0000950103-26-013643-index-headers.html0000950103-26-013643
Document: 0000950103-26-013643-index.html0000950103-26-013643
Document: 0000950103-26-013643.txt0000950103-26-013643
30 reports for SNN
Performance horizon
88% Hit rate 7 of 8 directional calls best @ T+20▲ +8.02%Jun 30, 2026
Filters
Rows
Reports for SNN — sortable, filterable
TypeNow
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 16, 2026
16d ago
6-K
NEUTRAL ★ 3/10
$27.80 $26.82▼ −3.53%▼ −6.09%$26.42 (−4.96%)
Sep 11, 2026
21d ago
6-K
NEUTRAL ★ 4/10
$27.50 $27.56▲ +0.22%▲ +0.44%$26.42 (−3.93%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 10, 2026
22d ago
6-K
NEUTRAL ★ 4/10
$27.62 $27.78▲ +0.58%▲ +1.08%$26.42 (−4.34%)
Sep 9, 2026
23d ago
6-K
NEUTRAL ★ 2/10
$27.80 $28.06▲ +0.94%▲ +1.27%$26.42 (−4.96%)
Sep 8, 2026
24d ago
424B5
NEUTRAL ★ 4/10
$27.87 $28.01▲ +0.50%▲ +1.62%$26.42 (−5.20%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 2, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.66 $27.62▼ −3.63%▼ −2.67%$26.42 (−7.82%)
Sep 1, 2026
4w ago
6-K
NEUTRAL ★ 2/10
$28.97 $27.80▼ −4.04%▼ −4.12%$26.42 (−8.80%)
Showing 10 of 30

US Market Status

Market Closed — Opens Mon (64h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access